openPR Logo
Press release

Exosome Display Technology for Antibody Generation, Targeted Delivery, and Protein Array Screen

08-05-2021 11:30 AM CET | Health & Medicine

Press release from: Creative Biolabs

Scientists now have realized that exosomes, representing a novel mode of intercellular communication, contribute to a wide range of biological processes in health and disease including cancer. Especially, growing evidence shows that tumor-derived exosomes play critical roles in cancer. Exosomes and their cargos may serve as cancer prognostic markers, therapeutic targets or even as anticancer drug‐carrier.
Exosome display is an innovative methodology enabling the manipulation of exosome protein content by the identification of addressing domains that mediate the specific distribution of proteins on exosomes. With years of experience in exosome research, Creative Biolabs provides exosome display services for antibody generation and isolation, targeted delivery, and protein array screen.
For generation and isolation of antibodies, Creative Biolabs is skillful in utilizing exosome display technology to develop antibodies against different drug targets, including difficult targets such as the G-protein coupled receptors (GPCRs). The scientist team is expert in ExoMAb technology, which does not require tedious and costly antigen purification, and can be done along with the purification of exosomes under non-denaturing conditions.
For targeted delivery research, Creative Biolabs offers custom services for the generation of targeted exosomes based on the exosome display technology, covering identification of exosome targeting peptides and construction of recombination exosomes.
For protein array screen, Creative Biolabs takes exosome display technology as a receptor presentation platform for GPCR-targeted drug screening of cognate ligands or small molecules, which can simultaneously analyze the binding of compounds or ligands to multiple receptors by combining the exosome display technology with protein array screening methods.
“Based on the advanced technology platform covering exosome characterization, purification, isolation and other related services, we can help accelerate the exosomal research in many ways. Clients can trust us for high quality, consistent reproducibility, and timeliness of delivery,” said Bella Smith, the Business Development Executive of Creative Biolabs.

NY, USA
marketing@creative-biolabs.com

About Creative Biolabs
Empowered by leading technology and years of experience in biomedical science, Creative Biolabs focuses on offering a full range of exosome-related services and products. The comprehensive services including exosome sampling, analysis, manufacturing, and exosome-based application. The high-quality exosome products involve all aspects of exosome research, such as exosome isolation tools, identification kits, and related antibodies (Flotillin 1 antibody, Alpha-synuclein polyclonal antibody, ceramide kinase polyclonal antibody, etc).

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exosome Display Technology for Antibody Generation, Targeted Delivery, and Protein Array Screen here

News-ID: 2346838 • Views:

More Releases from Creative Biolabs

Creative Biolabs-Improving Antibody Engineering Through Recombinant Approaches
Creative Biolabs-Improving Antibody Engineering Through Recombinant Approaches
Abstract: Creative Biolabs is a preeminent contract research organization (CRO) at the vanguard of recombinant antibody technologies, catering to the varied demands of scientists worldwide with high-quality human, humanized, and chimeric antibodies. To succeed or fail in the cutthroat field of antibody research, one must carefully consider the pros and cons of using human, humanized, or chimeric antibodies, and for researchers and pharmaceutical developers, it is crucial to understand the intricacies
Exosomes News: Creative Biolabs Introduces Exosome Purification Services for Car …
As exosomes can transmit the information of donor cells to recipient cells through the proteins, mRNA, miRNA carried by them, thus to realize the information and material exchange between cells, they have been a hot topic recently as being used as a drug carrier to transport drugs. "Future research may focus on how to improve the cargo loading of exosomes," said the senior scientist from Creative Biolabs, “at present, some
Creative Biolabs Upgrades Oncolytic Virus Product List for Immunotherapy Researc …
As early as around 1800, doctors discovered that certain cancer patients would have their symptoms reduced after being briefly infected with viruses. With the advancement of genetic engineering technology, the idea that viruses have the potential to improve and mediate immunotherapy has been established. Oncolytic viruses (OVs) are such kind of viruses that can replicate in tumor tissues, and kill tumor cells. Up to now, two OV drugs have been
Novel Strategies to Accelerate Research on Antibodies Against Exosomal Markers
Exosome, with a lipid bilayer membrane structure, is a tiny membrane vesicle that can be secreted by most cells. As a new research hotspot, exosomes have become a potentially effective method for disease diagnosis and treatment due to their wide existence in the body and convenient access, and have shown great potential in exosomal cargo loading and targeted delivery. Additionally, research on exosome antibodies may contribute to shaping the future

All 5 Releases


More Releases for Exosome

Emerging Trends to Reshape the Exosome Technologies Market: Creative Biolabs Lau …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Exosome Technologies Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the past few years, the exosome technologies market size has seen a significant exponential growth. The market is projected to expand from $0.07 billion in 2024 to $0.09 billion in 2025, with a compound
Exosome Therapy Market May See a Big Move | Major Giants- Exiqon, Exosome Diagno …
HTF MI recently introduced Global Exosome Therapy Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborating market size (2024-2031). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. The Major Players Covered in this Report: Sistemic Ltd Aethlon Medical, Inc. (United States), Exosome Diagnostic, Inc. (United States), Thermo Fisher Scientific, Inc. (United
Exosome Innovations Transforming Healthcare Solutions
The global exosome diagnostic and therapeutic market is witnessing remarkable growth, with its projected value reaching an astounding USD 22,609.77 million by 2034, up from USD 33.04 million in 2023. This meteoric rise represents a staggering compound annual growth rate (CAGR) of 81.03% from 2024 to 2034. As the market continues to expand, the spotlight is firmly on exosomes, small extracellular vesicles that play a significant role in a variety
Exosome Therapeutic Market : Detailed Overview
Introduction: The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,
Exosome Technologies Market Report 2024 - Exosome Technologies Market Size, Shar …
"The Business Research Company recently released a comprehensive report on the Global Exosome Technologies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The exosome technologies market size
Exosome technologies Market Growth Expected to See Next Level | Exosome Diagnost …
The Latest Study Published by HTF MI Research on the "Exosome technologies Market'' evaluates market size, trend and forecast to 2030. The Exosome technologies market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges as well